Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% |
|
-.--% | -.--% |
2024 | ThermoGenesis Holdings, Inc. Announces Resignation of Jeffery Cauble as Chief Financial Officer | CI |
2024 | ThermoGenesis Holdings, Inc. Receives A Notice of Default from Boyalife Group, Inc | CI |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -13.97 | -30.82 | -21.77 | -19.33 | -26.84 | |||||
Return on Total Capital | -28.48 | -54.42 | -32.56 | -27.21 | -37.21 | |||||
Return On Equity % | -264.13 | -495.46 | -256.39 | -351.55 | 14.5K | |||||
Return on Common Equity | -215.16 | -528.65 | -236.37 | -277.45 | -1.37K | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 43.66 | 12.92 | 37.58 | 25.85 | 20.44 | |||||
SG&A Margin | 51.59 | 80.21 | 96.09 | 73.13 | 76.45 | |||||
EBITDA Margin % | -20.2 | -85 | -70.99 | -50.24 | -57.46 | |||||
EBITA Margin % | -24.6 | -90.17 | -77.37 | -58.77 | -69.27 | |||||
EBIT Margin % | -25.55 | -91.29 | -77.8 | -59.08 | -69.6 | |||||
Income From Continuing Operations Margin % | -77.4 | -172.53 | -127.82 | -112.68 | -200.31 | |||||
Net Income Margin % | -72.79 | -167.81 | -122.43 | -107.51 | -190.31 | |||||
Net Avail. For Common Margin % | -72.79 | -167.81 | -122.43 | -107.51 | -190.31 | |||||
Normalized Net Income Margin | -33.03 | -103.11 | -78.88 | -65.25 | -99.57 | |||||
Levered Free Cash Flow Margin | -12.05 | -63.07 | -14.63 | -32.27 | 2.29 | |||||
Unlevered Free Cash Flow Margin | -8.6 | -69.39 | -12.66 | -32.05 | -19.26 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.87 | 0.54 | 0.45 | 0.52 | 0.62 | |||||
Fixed Assets Turnover | 4.79 | 3.87 | 4.66 | 2.99 | 1.72 | |||||
Receivables Turnover (Average Receivables) | 9.36 | 7.33 | 8.79 | 8.07 | 6.71 | |||||
Inventory Turnover (Average Inventory) | 1.77 | 1.81 | 1.03 | 1.79 | 3.17 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.48 | 2.49 | 2.36 | 0.95 | 0.44 | |||||
Quick Ratio | 0.66 | 1.39 | 1.26 | 0.52 | 0.25 | |||||
Operating Cash Flow to Current Liabilities | -0.49 | -2.34 | -1.04 | -0.63 | -0.32 | |||||
Days Sales Outstanding (Average Receivables) | 38.98 | 49.96 | 41.53 | 45.23 | 54.37 | |||||
Days Outstanding Inventory (Average Inventory) | 206.48 | 201.89 | 353.93 | 204.43 | 115.13 | |||||
Average Days Payable Outstanding | 105.7 | 47.32 | 91.16 | 66.84 | 57.76 | |||||
Cash Conversion Cycle (Average Days) | 139.77 | 204.53 | 304.29 | 182.82 | 111.74 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 634.28 | 133.48 | 313.87 | 332.98 | -314.79 | |||||
Total Debt / Total Capital | 86.38 | 57.17 | 75.84 | 76.9 | 146.56 | |||||
LT Debt/Equity | 621.4 | 123.19 | 283.87 | 109.12 | -80.92 | |||||
Long-Term Debt / Total Capital | 84.63 | 52.76 | 68.59 | 25.2 | 37.67 | |||||
Total Liabilities / Total Assets | 93.98 | 71.86 | 83.55 | 82.86 | 131.91 | |||||
EBIT / Interest Expense | -0.74 | -1.12 | -1.18 | -1.1 | -0.66 | |||||
EBITDA / Interest Expense | -0.57 | -1.03 | -1.01 | -0.86 | -0.5 | |||||
(EBITDA - Capex) / Interest Expense | -0.61 | -1.03 | -1.03 | -0.93 | -0.67 | |||||
Total Debt / EBITDA | -2.29 | -0.96 | -1.72 | -2.28 | -2.25 | |||||
Net Debt / EBITDA | -1.05 | -0.08 | -0.55 | -1.42 | -1.85 | |||||
Total Debt / (EBITDA - Capex) | -2.14 | -0.96 | -1.7 | -2.11 | -1.67 | |||||
Net Debt / (EBITDA - Capex) | -0.98 | -0.08 | -0.54 | -1.31 | -1.38 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 34.89 | -25.32 | -4.62 | 12.79 | -9.9 | |||||
Gross Profit, 1 Yr. Growth % | 159.74 | -77.9 | 177.44 | -22.42 | -28.75 | |||||
EBITDA, 1 Yr. Growth % | -71.09 | 214.19 | -19.07 | -20.17 | 3.04 | |||||
EBITA, 1 Yr. Growth % | -66.77 | 173.79 | -18.15 | -14.32 | 6.2 | |||||
EBIT, 1 Yr. Growth % | -65.95 | 166.88 | -18.71 | -14.35 | 6.15 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -75.33 | 66.46 | -29.33 | -0.57 | 60.17 | |||||
Net Income, 1 Yr. Growth % | -76.09 | 72.17 | -30.41 | -0.96 | 59.49 | |||||
Normalized Net Income, 1 Yr. Growth % | -30.73 | 133.11 | -27.03 | -6.7 | 37.48 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -84.43 | -22.43 | -62.96 | -52.88 | -62.89 | |||||
Accounts Receivable, 1 Yr. Growth % | -15.31 | 8.14 | -46.96 | 154.43 | -49.12 | |||||
Inventory, 1 Yr. Growth % | -14.89 | 68.69 | -8.58 | -37.95 | -57.83 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 12.69 | -25.39 | -14.95 | 182.53 | 11.98 | |||||
Total Assets, 1 Yr. Growth % | 4.13 | 37.11 | -1 | -6.13 | -42.06 | |||||
Tangible Book Value, 1 Yr. Growth % | -130.68 | -296.62 | -52.77 | 28.92 | -174.79 | |||||
Common Equity, 1 Yr. Growth % | -95.43 | 1.4K | -34 | 12.23 | -138.8 | |||||
Cash From Operations, 1 Yr. Growth % | -53.32 | 341.5 | -54.01 | 10.02 | -48.91 | |||||
Capital Expenditures, 1 Yr. Growth % | -85.3 | -87.36 | 304.35 | 330.11 | 333.25 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -59.98 | 398.65 | -77.88 | 148.77 | -106.39 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -67.17 | 764.49 | -82.6 | 185.59 | -45.86 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 1.09 | 0.37 | -15.6 | 3.72 | 0.81 | |||||
Gross Profit, 2 Yr. CAGR % | 6.1 | -24.23 | -21.69 | 46.71 | -25.65 | |||||
EBITDA, 2 Yr. CAGR % | -39.76 | -4.7 | 58.21 | -19.62 | -9.31 | |||||
EBITA, 2 Yr. CAGR % | -36.17 | -4.62 | 49.7 | -16.26 | -4.61 | |||||
EBIT, 2 Yr. CAGR % | -35.16 | -4.68 | 47.29 | -16.56 | -4.65 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 29.51 | -35.92 | 8.46 | -16.18 | 26.19 | |||||
Net Income, 2 Yr. CAGR % | 31 | -35.84 | 9.46 | -16.98 | 25.68 | |||||
Normalized Net Income, 2 Yr. CAGR % | -4.96 | 27.07 | 30.43 | -17.49 | 13.26 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -22.09 | -65.25 | -46.4 | -58.22 | -58.18 | |||||
Accounts Receivable, 2 Yr. CAGR % | -29.19 | -4.3 | -24.27 | 16.17 | 13.78 | |||||
Inventory, 2 Yr. CAGR % | -10.73 | 14.37 | 24.18 | -24.68 | -48.85 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -1.84 | -8.31 | -20.34 | 55.02 | 77.87 | |||||
Total Assets, 2 Yr. CAGR % | -45.44 | 19.49 | 16.51 | -3.6 | -26.25 | |||||
Tangible Book Value, 2 Yr. CAGR % | -1.16 | -22.34 | -3.64 | -21.97 | -1.81 | |||||
Common Equity, 2 Yr. CAGR % | -89.3 | -17.11 | 214.91 | -13.94 | -34.01 | |||||
Cash From Operations, 2 Yr. CAGR % | -36.01 | 43.57 | 42.5 | -28.87 | -25.03 | |||||
Capital Expenditures, 2 Yr. CAGR % | -32.12 | -86.37 | -28.52 | 317.03 | 331.68 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | - | 25.06 | 5.04 | -25.81 | -60.12 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | - | 40.64 | 22.64 | -29.51 | 24.34 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | - | -8.61 | -1.32 | -7.03 | -1.03 | |||||
Gross Profit, 3 Yr. CAGR % | - | -37.1 | 16.78 | -21.93 | 15.32 | |||||
EBITDA, 3 Yr. CAGR % | - | 4.46 | -10.23 | 25.95 | -12.69 | |||||
EBITA, 3 Yr. CAGR % | - | 3.71 | -9.36 | 24.29 | -9.36 | |||||
EBIT, 3 Yr. CAGR % | - | 3.91 | -9.6 | 22.94 | -9.59 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | - | 40.81 | -33.8 | 5.36 | 4.02 | |||||
Net Income, 3 Yr. CAGR % | - | 43.49 | -34.08 | 5.87 | 3.21 | |||||
Normalized Net Income, 3 Yr. CAGR % | - | 28.17 | 5.62 | 16.65 | -2.18 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | - | -22.2 | -64.5 | -48.65 | -59.84 | |||||
Accounts Receivable, 3 Yr. CAGR % | - | -18.46 | -21.39 | 13.43 | -11.78 | |||||
Inventory, 3 Yr. CAGR % | - | 7 | 6.14 | -1.46 | -37.92 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | - | -10.42 | -10.58 | 21.48 | 39.09 | |||||
Total Assets, 3 Yr. CAGR % | - | -25.82 | 12.23 | 8.41 | -18.65 | |||||
Tangible Book Value, 3 Yr. CAGR % | - | 24.31 | -34.2 | 6.18 | -23.07 | |||||
Common Equity, 3 Yr. CAGR % | - | -44.38 | -23.17 | 123.27 | -34.01 | |||||
Cash From Operations, 3 Yr. CAGR % | - | 21.82 | -1.76 | 30.73 | -36.3 | |||||
Capital Expenditures, 3 Yr. CAGR % | - | -61.24 | -57.81 | 30.02 | 322.37 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | - | - | -29.8 | 40.01 | -67.23 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | - | - | -29.92 | 62.56 | -35.45 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | - | - | - | -3.86 | -0.47 | |||||
Gross Profit, 5 Yr. CAGR % | - | - | - | -11.74 | -2.51 | |||||
EBITDA, 5 Yr. CAGR % | - | - | - | -6.23 | -9.86 | |||||
EBITA, 5 Yr. CAGR % | - | - | - | -4.79 | -7.49 | |||||
EBIT, 5 Yr. CAGR % | - | - | - | -4.82 | -7.65 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | - | - | 14.43 | -14.31 | |||||
Net Income, 5 Yr. CAGR % | - | - | - | 15.29 | -14.66 | |||||
Normalized Net Income, 5 Yr. CAGR % | - | - | - | 7.47 | 8.61 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | - | - | -39.33 | -62.1 | |||||
Accounts Receivable, 5 Yr. CAGR % | - | - | - | -6.06 | -8.86 | |||||
Inventory, 5 Yr. CAGR % | - | - | - | -7.02 | -20.73 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | - | - | 11.56 | 17.74 | |||||
Total Assets, 5 Yr. CAGR % | - | - | - | -17.63 | -5.12 | |||||
Tangible Book Value, 5 Yr. CAGR % | - | - | - | 3.18 | -22.78 | |||||
Common Equity, 5 Yr. CAGR % | - | - | - | -33.76 | -27.71 | |||||
Cash From Operations, 5 Yr. CAGR % | - | - | - | -1.77 | -11.83 | |||||
Capital Expenditures, 5 Yr. CAGR % | - | - | - | 0.25 | 6.96 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | - | - | -44.01 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | - | - | -11.86 |
- Stock Market
- Equities
- THMO Stock
- Financials ThermoGenesis Holdings, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions